Arizona State Retirement System Cytom X Therapeutics, Inc. Transaction History

Arizona State Retirement System

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 04, 2022	SELL	$3.87 - $7.39 $54,826 - $104,694	-14,167 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.32 - $6.43 $341 - $507	79 Added 0.56%	14,167 $72,000
Q2 2021 Aug 02, 2021	SELL	$6.33 - $9.91 $5,595 - $8,760	-884 Reduced 5.9%	14,088 $89,000
Q1 2021 May 06, 2021	BUY	$6.6 - $9.0 $19,628 - $26,766	2,974 Added 24.79%	14,972 $116,000
Q4 2020 Jan 28, 2021	SELL	$6.47 - $7.9 $3,060 - $3,736	-473 Reduced 3.79%	11,998 $79,000
Q3 2020 Nov 05, 2020	BUY	$6.55 - $8.83 $81,685 - $110,118	12,471 New	12,471 $83,000
Q2 2020 Aug 04, 2020	SELL	$7.4 - $14.64 $78,928 - $156,150	-10,666 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$3.61 - $8.6 $38,504 - $91,727	10,666 New	10,666 $82,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.